Shenzhen Capchem Technology Future Growth
Future criteria checks 5/6
Shenzhen Capchem Technology is forecast to grow earnings and revenue by 29% and 22.9% per annum respectively. EPS is expected to grow by 28.8% per annum. Return on equity is forecast to be 17.3% in 3 years.
Key information
29.0%
Earnings growth rate
28.8%
EPS growth rate
Chemicals earnings growth | 39.6% |
Revenue growth rate | 22.9% |
Future return on equity | 17.3% |
Analyst coverage | Good |
Last updated | 04 Nov 2024 |
Recent future growth updates
Recent updates
We Think Shenzhen Capchem Technology (SZSE:300037) Can Stay On Top Of Its Debt
Oct 18Shenzhen Capchem Technology Co., Ltd.'s (SZSE:300037) P/E Is Still On The Mark Following 25% Share Price Bounce
Sep 30Many Still Looking Away From Shenzhen Capchem Technology Co., Ltd. (SZSE:300037)
May 24Shenzhen Capchem Technology (SZSE:300037) Has Announced That It Will Be Increasing Its Dividend To CN¥0.60
May 03Investors Met With Slowing Returns on Capital At Shenzhen Capchem Technology (SZSE:300037)
Apr 23Shenzhen Capchem Technology Co., Ltd. (SZSE:300037) Analysts Just Cut Their EPS Forecasts Substantially
Apr 05Shenzhen Capchem Technology (SZSE:300037) Seems To Use Debt Quite Sensibly
Feb 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 12,790 | 1,994 | -721 | 2,424 | 10 |
12/31/2025 | 10,316 | 1,521 | -514 | 2,303 | 11 |
12/31/2024 | 7,711 | 1,121 | -242 | 969 | 8 |
9/30/2024 | 7,568 | 915 | -575 | 756 | N/A |
6/30/2024 | 7,633 | 910 | 37 | 1,585 | N/A |
3/31/2024 | 7,352 | 931 | 642 | 2,316 | N/A |
12/31/2023 | 7,484 | 1,011 | 1,658 | 3,448 | N/A |
9/30/2023 | 7,915 | 1,113 | 828 | 2,857 | N/A |
6/30/2023 | 8,103 | 1,271 | 456 | 2,483 | N/A |
3/31/2023 | 8,596 | 1,492 | 62 | 2,030 | N/A |
1/1/2023 | 9,661 | 1,758 | 50 | 1,810 | N/A |
9/30/2022 | 9,811 | 1,881 | 488 | 1,816 | N/A |
6/30/2022 | 9,386 | 1,874 | 452 | 1,448 | N/A |
3/31/2022 | 8,524 | 1,663 | 257 | 1,019 | N/A |
12/31/2021 | 6,951 | 1,307 | -149 | 449 | N/A |
9/30/2021 | 5,424 | 1,012 | -29 | 551 | N/A |
6/30/2021 | 4,324 | 717 | -25 | 488 | N/A |
3/31/2021 | 3,580 | 575 | 248 | 749 | N/A |
12/31/2020 | 2,961 | 518 | 416 | 881 | N/A |
9/30/2020 | 2,633 | 460 | 180 | 591 | N/A |
6/30/2020 | 2,462 | 429 | 33 | 535 | N/A |
3/31/2020 | 2,333 | 362 | -21 | 481 | N/A |
12/31/2019 | 2,325 | 325 | 40 | 561 | N/A |
9/30/2019 | 2,310 | 351 | 61 | 564 | N/A |
6/30/2019 | 2,235 | 333 | 145 | 542 | N/A |
3/31/2019 | 2,228 | 330 | 70 | 464 | N/A |
12/31/2018 | 2,165 | 320 | -24 | 352 | N/A |
9/30/2018 | 2,092 | 284 | -79 | 262 | N/A |
6/30/2018 | 2,014 | 274 | N/A | 304 | N/A |
3/31/2018 | 1,877 | 264 | N/A | 258 | N/A |
12/31/2017 | 1,816 | 280 | N/A | 192 | N/A |
9/30/2017 | 1,746 | 270 | N/A | 157 | N/A |
6/30/2017 | 1,694 | 258 | N/A | 155 | N/A |
3/31/2017 | 1,679 | 270 | N/A | 147 | N/A |
12/31/2016 | 1,589 | 256 | N/A | 189 | N/A |
9/30/2016 | 1,404 | 238 | N/A | 173 | N/A |
6/30/2016 | 1,223 | 211 | N/A | 157 | N/A |
3/31/2016 | 1,061 | 169 | N/A | 91 | N/A |
12/31/2015 | 934 | 128 | N/A | 104 | N/A |
9/30/2015 | 850 | 112 | N/A | 80 | N/A |
6/30/2015 | 790 | 106 | N/A | 55 | N/A |
3/31/2015 | 763 | 114 | N/A | 110 | N/A |
12/31/2014 | 757 | 133 | N/A | 133 | N/A |
9/30/2014 | 730 | 138 | N/A | 160 | N/A |
6/30/2014 | 714 | 141 | N/A | 178 | N/A |
3/31/2014 | 698 | 133 | N/A | 164 | N/A |
12/31/2013 | 684 | 125 | N/A | 119 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300037's forecast earnings growth (29% per year) is above the savings rate (2.8%).
Earnings vs Market: 300037's earnings (29% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 300037's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300037's revenue (22.9% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 300037's revenue (22.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300037's Return on Equity is forecast to be low in 3 years time (17.3%).